Uppsala Therapeutics AB
559027-4204ActiveDeveloping nanoparticle platforms for targeted drug delivery across the BBB.
Översikt
- 0
- Anställda
- ≤1t SEK
- Omsättning
- 2015
- Grundat
Nyckelbeslutsfattare
Oommen Varghese
Co-Founder, Chief Scientific Officer (CSO)
Jöns Hilborn
Co-Founder
Victor Hartman
CEO
O. P. Oommen
Co-Founder
Beskrivning
Uppsala Therapeutics is an innovative biopharmaceutical company specializing in advanced drug delivery systems. The core of their work involves developing proprietary nanoparticle-based therapies designed to carry small molecule and oligonucleotide drugs. Their technology originates from cutting-edg...
Taggar
Nyckelord
Företagsinformation
- Bransch
- Bioteknisk forskning och utveckling
- Juridisk form
- Aktiebolag
- Momsnummer
- SE559027420401
Beslutsfattare
4 kontakter i FunnelfeedrOommen Varghese
Co-Founder, Chief Scientific Officer (CSO)
Jöns Hilborn
Co-Founder
Victor Hartman
CEO
O. P. Oommen
Co-Founder
Liknande företag
20 liknande företag i FunnelfeedrKey2Brain AB
10–19 anställdaDeveloping proprietary technology for next-generation brain targeting therapeutics.
Double Bond Pharmaceutical AB
5–9 anställdaDeveloping advanced drug delivery systems for targeted cancer and pneumonia treatment.
Ambusol AB (publ)
1–4 anställdaPioneering patented therapy to eradicate residual glioblastoma cells post-surgery.
Strike Pharma AB
4 anställdaSwedish biotech developing targeted LNP delivery for in vivo CAR-T therapies.
Theralia AB
0 anställdaPioneering biotech revolutionizing drug delivery via TOUCAN technology.
Utforska mer
Frågor om Uppsala Therapeutics AB
Vill du se Funnelfeedr i praktiken?
Boka en gratis demo och upptäck hur Funnelfeedr hjälper dig att hitta och konvertera dina idealkunder.
Boka en demo